Toxicity is an important factor in failed drug development, and its efficient 20 identification and prediction is a major challenge in drug discovery. We have explored 21 the potential of microscopy images of fluorescently labeled nuclei for the prediction of 22 toxicity based on nucleus pattern recognition. Deep learning algorithms obtain 23 abstract representations of images through an automated process, allowing them to 24 efficiently classify complex patterns, and have become the state-of-the art in machine 25 learning for computer vision. Here, deep convolutional neural networks (CNN) were 26 trained to predict toxicity from images of DAPI-stained cells pre-treated with a set of 27 drugs with differing toxicity mechanisms. Different cropping strategies were used for 28 training CNN models, the nuclei-cropping-based Tox-CNN model outperformed other 29 models classifying cells according to health status. Tox-CNN allowed automated 30 extraction of feature maps that clustered compounds according to mechanism of 31 action. Moreover, fully automated region-based CNNs (RCNN) were implemented to 32 detect and classify nuclei, providing per-cell toxicity prediction from raw screening 33
We asked ourselves if it would be possible to train machines to detect cytotoxicity 48 from microscopy images of fluorescently stained nuclei, without using specific toxicity 49 labeling. Deep learning is the most powerful supervised machine learning methodology 50 available, with exceptional abilities to solve computer vision tasks, and was thus 51 selected for the development of a toxicity quantification tool. Two convolutional 52 neural networks (CNN) were developed to classify cells based on health status: Tox-53 CNN, relying on prior cell segmentation and cropping of nuclei images, and Tox-RCNN 54 which carries out fully-automated cell detection and classification. Both Tox-(R)CNN 55 classification outputs provided sensitive screening readouts that detected pre-lethal 56 toxicity and were validated for a broad array of toxicity pathways and cell assays. Tox-Introduction 60 Toxicity is a major cause of failure in drug development and causes costly 61 withdrawals of drugs from the market. Drug development productivity would be 62 greatly improved if cytotoxic compounds were identified during early in vitro screening 63 [1] [2] [3] [4] . Drug-induced cytotoxic effects lead to changes in cell and nuclear morphology 64 which are characteristic of the specific cell-death pathway involved, the best 65 characterized being apoptosis, necrosis, and autophagy [5] [6] [7] . The field has advanced 66 with the establishment of high content screening (HCS) techniques and the emergence 67 of toxicity reporters revealing specific biochemical pathways triggered during cell 68 death programs or measuring metabolic cell function [8] [9] [10] . However, toxicity 69 reporters are often limited to assess the specific biochemical pathways for which they 70 were designed [11] [12] [13] , and they are thus unlikely to capture the wide variety of toxic 71 effects that can be triggered by different drugs in screening campaigns. Toxicity-72 screening approaches have combined multi-parametric image analysis of fluorescently 73 labeled nuclei with the use of toxicity reporters in advanced machine learning pipelines 74 [14] [15] [16] [17] [18] . However, toxicity reporters increase experimental complexity, thus reducing 75 throughput and increasing screening costs. There is therefore an urgent need to 76 develop broad specificity, cost-effective in vitro toxicity assays for incorporation in the 77 primary screening phases of drug development. Cytotoxic effects have classically been 78 visually identified from cell and nuclear morphology [5] [6] [7] . However, the complexity 79 and variability of toxicity-associated morphological patterns has so far hindered their 80 systematic and quantitative analysis and thus prevented their use as standalone 81 toxicity screening endpoints. Although nuclear fluorescence staining forms the basis of 82 most high content cell-based assays, its use is normally limited to image segmentation 5 83 and nuclei counting to score cell-loss due to lethal toxicity [19, 20] , thus disregarding 84 the wealth of information contained in images of fluorescently labeled nuclei. In an 85 effort to exploit this information for the quantification of pre-lethal toxicity, we have 86 explored state-of the-art machine learning tools for automated pattern recognition. 87 The success of classical learning-based computer vision methods relies heavily on 88 extraction and selection of a reasonable set of relevant features that are highly 89 discriminative of the phenotypes being studied. Feature selection requires in-depth 90 knowledge of the phenotype under study, which is hindered in the current application 114 To test if CNNs can predict cell toxicity based exclusively on nuclear staining, we 115 designed an experimental assay in which HL1 cells were treated with reference 116 compounds at different concentrations. We used previously established dose-curves to 117 guarantee varying degrees of toxicity outcome. The included reference compounds 118 cover a range of cytotoxic effects: the DNA targeting genotoxic drugs 119 cyclophosphamide (Ciclo), 5-fluorouracil (5Fluo), and doxorubicin (Doxo); the 120 apoptosis-triggering drug staurosporine (Staur); the enzyme inhibitors acetaminophen 121 (Aceta) and sunitinib (Sunit), which are not associated with a specific toxicity 122 mechanism; the uncoupler of mitochondrial oxidative metabolism FCCP; and the 123 microtubule stabilizer Taxol, which inhibits mitosis. Cells were labeled with the DNA-124 specific fluorescent probe DAPI and imaged with an automated confocal microscope, 125 revealing a great variety of nuclear patterns induced by the different compounds (Fig   126   1A ). The standard toxicity readout of nucleus count (Num Nuc) revealed cell loss due 127 to drug-induced lethal effects, but did not reveal the great variety of toxic effects 128 associated with the reference compounds assayed ( Fig 1B) . As reference standards, we 318 To further evaluate the Tox-(R)CNN deep-learning models as screening tools for 319 prioritizing compounds based on their toxicity potential, we re-analyzed a pre-320 accomplished HCS of primary pancreatic cancer associated fibroblasts (pan-CAFs). 321 Among several assay-specific labels, most of which are irrelevant here (not shown), 16 322 this HCS included DAPI staining in the assay for both image segmentation and nuclei 323 counting as a toxicity endpoint. A transfer learning strategy was applied to the Tox-324 (R)CNN models delivering (Tr_Tox_(R)CNN) models. Training strategy was designed to 325 allow the use of pre-run screens lacking reference toxicity-inducing treatments (see 326 Materials and Methods). In brief, the training dataset was produced from images from 327 drug-treated wells with a significantly reduced cell number, which were labeled 328 toxicity affected, while cells from DMSO treated wells were labeled healthy, since no 329 untreated cells were available for training. Interestingly, compounds #19 and #33 330 (anagrelide and quercetin) were negligibly lethal according to nuclei counting, but 331 were predicted by Tox-CNN to be toxic at high concentrations (Fig 5A,B) , avoid off-centered nuclei crops, those nuclei with a distance to field image boundaries 499 of less than 50 pixels were excluded from the cropping extraction and further analysis. 500 Aditionally, bounding box coordinates from segmented cells were also extracted for 501 training automatic object detection by RCNN.
Results
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CNN can predict cell toxicity based on images of fluorescently stained nuclei
Validation of Tox-(R)CNN models as toxicity screening tools
503
Convolutional neural network (Tox-CNN) 504 We designed the toxicity convolutional neural network with 4 convolutional and 2 505 fully connected layers ( Fig 1E) to classify single-cell images as "healthy" or "toxicity 506 affected". The Rectified Linear Unit (ReLU) activation function is applied between each 507 layer except the output dense layer, which uses a softmax activation function to 508 provide a separate probability for each of the classes. Convolutional layers convolve a 509 3×3 kernel over some input to produce 32, 32, 64, and 64 feature maps, respectively. 510 To reduce the number of features and the computational complexity of the network, 511 we introduced two max-pooling layers with a window size of 2×2 after convolutional 512 layers 2 and 4. Additionally, to avoid overfitting, we included two dropout blocks after 513 convolutional layers 2 and 4, and another one next to the first fully connected layer. 514 Dropout deactivates some neurons randomly with a probability of 25% during the 515 weight update cycle. The final max-pooling layer is then flattened and followed by two 516 densely connected layers with 512 and 2 features. Finally, we applied a softmax 517 activation function to the output of last fully connected layer to calculate the 518 probability for each class label. The total number of parameters to learn is equal to 519 4,031,458, most of them belong to the first fully connected layer. We used ADADELTA 520 algorithm [33] to adjust the learning rate automatically. To increase the number of 521 data and avoid overfitting, we augmented images by applying random rotations in the modifications were applied randomly, so not every image will be changed every time. 526 Images were normalized to zero mean and unit variance before feeding them into the 527 network.
529
Region based Convolutional Neural Networks (Tox-RCNN) 530 We used state-of-the-art Faster Region-Based CNN [29] (RCNN) to both detect and 531 classify cells as "healthy" or "toxicity affected" from entire images. Faster RCNN is
